ArticleNucleic acids research2026
A Tel1-Rad9 axis links DNA double-strand break end-tethering to repair pathway choice.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In eukaryotes, DNA double-strand breaks (DSBs) activate Tel1/ATM- and Mec1/ATR-dependent checkpoint signaling and can be repaired by homologous recombination (HR), which requires DNA end resection, typically initiated by the MRX/MRN complex. In budding yeast, Sae2/CtIP promotes MRX-dependent end processing, limits Tel1-Rad53 signaling, and contributes to DSB end-tethering. Here, we identify a Tel1 FAT-domain variant, Tel1-400, that increases the DNA damage resistance of sae2Δ cells by suppressing their DSB end-tethering defect through Rad9 phosphorylation-dependent oligomerization. Tel1-400 accumulates more strongly at DSBs than wild-type Tel1 and enhances DNA-damage-induced Rad9 phosphorylation. An oligomerization-defective rad9 phosphosite mutant prevents Tel1-400 from improving DSB end-tethering in sae2Δ cells, whereas chemically induced Rad9 dimerization restores this ability. Rad9 also supports DSB end-tethering in Sae2-proficient cells, as the same rad9 phosphosite mutant increases end separation in an otherwise wild-type background. Functionally, Tel1-400 shifts repair in sae2Δ cells toward strand-invasion-dependent HR while reducing single-strand annealing, and this repair-pathway bias requires Rad9 oligomerization. Together, these findings identify a Tel1-Rad9 pathway in which increased Tel1 association at DNA breaks enhances Rad9 phosphorylation and self-assembly, thereby promoting DSB end-tethering and influencing recombination pathway choice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.